1
TÍTULO: Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1  Full Text
AUTORES: Pramod K Mistry; Manisha Balwani; Hagit N Baris; Hadhami Ben Turkia; Andrew A Burrow; Joel Charrow; Gerald F Cox; Sumita Danda; Marta Dragosky; Guillermo Drelichman; Amal El Beshlawy; Cristina Fraga; Selena Freisens; Sebastiaan Gaemers; Evgueniy Hadjiev; Priya S Kishnani; Elena Lukina; Pierre Maison Blanche; Ana Maria Martins; Gregory Pastores; Milan Petakov; Judith J Peterschmitt; Hanna Rosenbaum; Barry Rosenbloom; Lisa H Underhill; Timothy M Cox; ...Mais
PUBLICAÇÃO: 2019, FONTE: BLOOD CELLS MOLECULES AND DISEASES, VOLUME: 77
INDEXADO EM: Scopus WOS
2
TÍTULO: Cause of death in patients with attenuated acid sphingomyelinase deficiency: Comprehensive literature review and report of new cases  Full Text
AUTORES: Jackie Imrie; Karl Eugen Mengel; David Cassiman; Paulina Mabe; Moeen Al Sayed; Bruno Bembi; Roberto Giugliani; Seymour Packman; Manuel Schiff; Tsutomu Takahashi; Hadhami Ben Turkia; Gerald F Cox;
PUBLICAÇÃO: 2016, FONTE: 12th Annual WORLD Symposium in MOLECULAR GENETICS AND METABOLISM, VOLUME: 117, NÚMERO: 2
INDEXADO EM: WOS CrossRef
3
TÍTULO: Gaucher disease in Tunisia: High frequency of the most common mutations  Full Text
AUTORES: Wafa Cherif; Hadhami Ben Turkia; Faten Ben Rhouma; Imene Riahi; Jalel Chemli; Rym Kefi; Habib Messai; Olga Amaral; Maria Clara S Sa Miranda ; Catherine Caillaud; Neji Tebib; Marie Francoise Ben Dridi; Sonia Abdelhak;
PUBLICAÇÃO: 2009, FONTE: BLOOD CELLS MOLECULES AND DISEASES, VOLUME: 43, NÚMERO: 2
INDEXADO EM: Scopus WOS CrossRef